Clinical Trial Update: Cyclophosphamide and Fludarabine to Treat Lupus Nephritis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating cyclophosphamide and fludarabine for lupus nephritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glomerulonephritis
• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Glomerulonephritis, Lupus Nephritis | Phase 1 | Status: COMPLETED